The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013
Open accessAbstract
Importance: It is important to understand the magnitude and distribution of the economic burden of prescription opioid overdose, abuse, and dependence to inform clinical practice, research, and other decision makers. Decision makers choosing approaches to address this epidemic need cost information to evaluate the cost effectiveness of their choices. Objective: To estimate the economic burden of prescription opioid overdose, abuse, and dependence from a societal perspective. Design, Setting, and Participants: Incidence of fatal prescription opioid overdose from the National Vital Statistics System, prevalence of abuse and dependence from the National Survey of Drug Use and Health. Fatal data are for the US population, nonfatal data are a nationally representative sample of the US civilian noninstitutionalized population ages 12 and older. Cost data are from various sources including health care claims data from the Truven Health MarketScan Research Databases, and cost of fatal cases from the WISQARS (Web-based Injury Statistics Query and Reporting System) cost module. Criminal justice costs were derived from the Justice Expenditure and Employment Extracts published by the Department of Justice. Estimates of lost productivity were based on a previously published study. Exposure: Calendar year 2013. Main Outcomes and Measures: Monetized burden of fatal overdose and abuse and dependence of prescription opioids. Results: The total economic burden is estimated to be $78.5 billion. Over one third of this amount is due to increased health care and substance abuse treatment costs ($28.9 billion). Approximately one quarter of the cost is borne by the public sector in health care, substance abuse treatment, and criminal justice costs. Conclusions and Relevance: These estimates can assist decision makers in understanding the magnitude of adverse health outcomes associated with prescription opioid use such as overdose, abuse, and dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“many of these domains are featured in existing studies of the economic burden of SUDs”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“This is a change from previously published estimates, where a large share of costs was attributable to opioid use disorder (Birnbaum et al., 2011; Florence et al., 2016; Rice et al., 2014).”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Matching controlled for basic demographic variables, health status was matched based on the Charlson comorbidity index and health care costs prior to use disorder diagnosis, and regression models controlled for skewness in the expenditure data.”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The original source study used a matched case-control design to estimate the impact of opioid use disorder diagnoses on health care spending.”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350
Pharmaceutical Overdose Deaths, United States, 2010
Jones, C. M., Mack, K. A., & Paulozzi, L. J. (2013) · JAMA · doi:10.1001/jama.2013.272 · Cited by 678
Societal costs of prescription opioid abuse, dependence, and misuse in the United States
Birnbaum, H. G., White, A. G., Schiller, M., Waldman, T., Cleveland, J. M., & Roland, C. L. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01075.x · Cited by 644
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
(2011) · PubMed · Cited by 640
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 502
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 494
Economic Costs of Nonmedical Use of Prescription Opioids
Hansen, R. N., Oster, G., Edelsberg, J., WOODY, G. E., & Sullivan, S. D. (2010) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181ff04ca · Cited by 183
Economic Burden of Prescription Opioid Misuse and Abuse
Strassels, S. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.7.556 · Cited by 148
Estimated Costs of Prescription Opioid Analgesic Abuse in the United States in 2001
Birnbaum, H. G., White, A. G., Reynolds, J. L., Greenberg, P. E., Zhang, M., Vallow, S., Schein, J. R., & Katz, N. P. (2006) · Clinical Journal of Pain · doi:10.1097/01.ajp.0000210915.80417.cf · Cited by 139
Ballesteros, M. F., Webb, K. B., & McClure, R. (2017) · Journal of Safety Research · doi:10.1016/j.jsr.2017.01.001 · Cited by 126
Cited by
Sorted by citations
Items 401–500 of 1,000
Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder
Larochelle, M. R., Wakeman, S. E., Ameli, O., Chaisson, C. E., McPheeters, J., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020) · Medical Care · doi:10.1097/mlr.0000000000001394 · Cited by 17
Adams, J. W., Savinkina, A. A., Fox, A. D., Behrends, C. N., Madushani, R. W. M. A., Wang, J., Chatterjee, A., Walley, A. Y., Barocas, J. A., & Linas, B. P. (2022) · Addiction · doi:10.1111/add.15883 · Cited by 17
Liao, S. X., Jang, S., Tharp, J. A., & Lester, N. A. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209139 · Cited by 17
Poore, H. E., Hatoum, A. S., Mallard, T. T., Sanchez‐Roige, S., Waldman, I. D., Palmer, A. A., Harden, K. P., Barr, P. B., & Dick, D. M. (2023) · Addiction Biology · doi:10.1111/adb.13319 · Cited by 21
Potentially Problematic Opioid Prescriptions Among Individuals With Private Insurance and Medicaid
Ali, M. M., Tehrani, A. B., Mutter, R. L., Henke, R. M., O’Brien, M., Pines, J. M., & Mazer-Amirshahi, M. E. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800555 · Cited by 17
Nolan, K., Zullo, A. R., Bosco, E., Marchese, C., & Berard-Collins, C. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz116 · Cited by 17
Bowen, E. A., & Irish, A. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.09.014 · Cited by 18
Prescription opioids and new business establishments
Rietveld, C. A., & Patel, P. C. (2020) · Small Business Economics · doi:10.1007/s11187-020-00343-x · Cited by 17
The pharmacogenetics of opioid treatment for pain management
Singh, A., Zai, C. C. H., Mohiuddin, A. G., & Kennedy, J. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120944162 · Cited by 17
Opioid Prescribing Trends and Geographic Variation After Anterior Cruciate Ligament Reconstruction
Marrache, M., Best, M. J., Raad, M., Mikula, J. D., Amin, R. M., & Wilckens, J. H. (2020) · Sports Health A Multidisciplinary Approach · doi:10.1177/1941738120954432 · Cited by 17
Sun, J. W., Franklin, J. M., Rough, K., Desai, R. J., Hernández–Dı́az, S., Huybrechts, K. F., & Bateman, B. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241083 · Cited by 17
The pathophysiology of opioid-induced respiratory depression
Montandon, G. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91534-2.00003-5 · Cited by 17
Sharma, M., Ugiliweneza, B., Aljuboori, Z., & Boakye, M. (2018) · Neurosurgical FOCUS · doi:10.3171/2018.2.focus17764 · Cited by 17
Anne, S., Mims, J. “., Tunkel, D. E., Rosenfeld, R. M., Boisoneau, D. S., Brenner, M. J., Cramer, J. D., Dickerson, D. M., Finestone, S. A., Folbe, A. J., et al. (2021) · Otolaryngology · doi:10.1177/0194599821996303 · Cited by 17
Elder, J. W., Wu, E. F., Chenoweth, J., Holmes, J. F., Parikh, A. K., Moulin, A. K., Trevino, T. G., & Richards, J. R. (2020) · Emergency Medicine International · doi:10.1155/2020/8275386 · Cited by 16
Hocker, A. D., Morrison, N. R., Selby, M., & Huxtable, A. G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.604593 · Cited by 16
Safety evaluation of oliceridine for the management of postoperative moderate-to-severe acute pain
Tan, H. S., & Habib, A. S. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1965989 · Cited by 16
Watson, H., Hildebolt, C. F., & Rowland, K. C. (2021) · Pain Medicine · doi:10.1093/pm/pnab334 · Cited by 16
Short, N. A., Austin, A. E., & Naumann, R. B. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107507 · Cited by 17
Healthcare utilization and costs associated with treatment for opioid dependence
Shah, A. M., Duncan, M. E., Atreja, N., Tai, K., & Gore, M. R. (2018) · Journal of Medical Economics · doi:10.1080/13696998.2018.1427101 · Cited by 17
Witkiewitz, K. A., Votaw, V. R., Vowles, K. E., & Kranzler, H. R. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13772 · Cited by 16
Role of regional anesthesia and analgesia in the opioid epidemic
Lee, B. H., Kumar, K., Wu, E. C., & Wu, C. L. (2019) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2018-100102 · Cited by 16
Quantifying the use of opioids in the immediate postoperative period after endoscopic sinus surgery
Badash, I., Lui, C. G., Hur, K., Acevedo, J. R., Ference, E. H., & Wrobel, B. (2019) · The Laryngoscope · doi:10.1002/lary.28178 · Cited by 16
Hockley, A., Ge, D. H., Vasquez-Montes, D., Moawad, M. A., Passias, P. G., Errico, T. J., Buckland, A. J., Protopsaltis, T. S., & Fischer, C. R. (2020) · European Spine Journal · doi:10.1007/s00586-020-06345-3 · Cited by 16
A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder
Seguí, H. A., Melín, K., Santiago, D., & Duconge-Soler, J. (2020) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2020.35 · Cited by 16
Drug Misuse in the Veterinary Setting: an Under-recognized Avenue
Anand, A., & Hosanagar, A. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-020-01214-8 · Cited by 16
Bastawrous, A. L., Brockhaus, K. K., Chang, M. I., Milky, G., Shih, I., Li, Y., & Cleary, R. K. (2021) · Surgical Endoscopy · doi:10.1007/s00464-021-08338-9 · Cited by 16
Crisis, what crisis? Addiction neuroscience and the challenges of translation
McLean, S., & Rose, N. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16265.1 · Cited by 15
Howell, B. A., Martin, R. A., Lebeau, R., Truong, A. Q., Wang, E. A., Rich, J. D., & Clarke, J. G. (2021) · Health Affairs · doi:10.1377/hlthaff.2020.02156 · Cited by 15
Matthews, T. A., Sembajwe, G. N., von Känel, R., & Li, J. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.04.001 · Cited by 15
Li, K., Chen, S., Wang, C., & Yang, L. (2022) · Journal of Robotic Surgery · doi:10.1007/s11701-022-01491-w · Cited by 15
Paul, A., Banga, I. K., Muthukumar, S., & Prasad, S. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c14246 · Cited by 15
Chu, L. F., Sun, J. S., Clemenson, A., Erlendson, M. J., Rico, T., Cornell, E., Obasi, H., Sayyid, Z. N., Encisco, E. M., Yu, J., et al. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000321 · Cited by 15
Donohue, J. M., Barry, C. L., Stuart, E. A., Greenfield, S. F., Song, Z., Chernew, M. E., & Huskamp, H. A. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000368 · Cited by 15
Novel Formulations of Buprenorphine for Treatment of Opioid Use Disorder
Rosenthal, R. N. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20180043 · Cited by 15
Gudin, J. A., Rauck, R. L., Argoff, C. E., Agaiby, E., Gimbel, J. S., Katz, N. P., Doberstein, S. K., Tagliaferri, M. A., Tagliaferri, M. C., Potts, J., et al. (2019) · Pain Medicine · doi:10.1093/pm/pnz169 · Cited by 15
Gifford, E. D., Hanson, K. T., Davila, V. J., Oldenburg, W. A., Colglazier, J. J., Money, S. R., Hakaim, A. G., Stone, W. M., Farres, H., Habermann, E. B., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.05.068 · Cited by 15
Development of Abuse-Deterrent Formulations Using Sucrose Acetate Isobutyrate
Ali, S. F. B., Dharani, S., Afrooz, H., Mohamed, E. M., Cook, P., Khan, M. A., & Rahman, Z. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01646-8 · Cited by 15
Opioid consumption following orthopedic shoulder surgery: a retrospective analysis
Vattigunta, S., Weiner, S. D., Nayar, S. K., Jenkins, S. G., & Srikumaran, U. (2021) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2021.04.005 · Cited by 15
Lin, Y.-M., Tang, Y., Fu, Y., Hegde, S., Shi, D. W., Huang, L.-Y. M., & Shi, X.-Z. P. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2020 · Cited by 15
Hasan, M. M., Noor‐E‐Alam, M., Mohite, P., Islam, M. S., Modestino, A., Peckham, A. M., Young, L. D., & Young, G. J. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108416 · Cited by 15
Morgenstern, C., Ramírez-Paesano, C. R., Galceran, A. J., & Morgenstern, R. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.06.152 · Cited by 15
Walker, D. M., Childerhose, J. E., Chen, S., Coovert, N., Jackson, R. D., Kurien, N., McAlearney, A. S., Volney, J., Alford, D. P., Bosak, J., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109342 · Cited by 15
Screening emergency department patients for opioid drug use: A qualitative systematic review
Sahota, P. K., Shastry, S., Mukamel, D. B., Murphy, L. S.-L., Yang, N., Lotfipour, S., & Chakravarthy, B. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.05.022 · Cited by 15
Gruß, I., Firemark, A. J., Mayhew, M., McMullen, C. K., & DeBar, L. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.08.009 · Cited by 18
Kiechle, J. E., & Gonzalez, C. M. (2017) · Urology · doi:10.1016/j.urology.2017.10.009 · Cited by 15
Embracing Remote Fields as the Fourth Dimension of Tissue Biofabrication
Anand, S., Müller, C., Jensen, B. N., & Chen, M. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202401654 · Cited by 14
Current Impact and Application of AbuseDeterrent Opioid Formulations in Clinical Practice
Chen, H. (2017) · Pain Physician · doi:10.36076/ppj/2017.7.e1003 · Cited by 14
Cook, A. K., & Worcman, N. (2019) · Health & Justice · doi:10.1186/s40352-019-0095-8 · Cited by 14
Ahmad, R., & Omidian, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118602 · Cited by 14
Li, G., & Chihuri, S. T. (2020) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-020-00257-7 · Cited by 14
Crowley, J. S., McLean, P., Gabriel, R. A., Cronin, B. J., Hsieh, S. T., Englar, K., Said, E. T., Lance, S. H., & Gosman, A. A. (2020) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000006310 · Cited by 14
Richmond, J. R., Tull, M. T., & Gratz, K. L. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2020.03.002 · Cited by 14
Adewumi, A. D., Maravilla, J. C., Alati, R., Hollingworth, S., Hu, X., Loveday, B., & Connor, J. P. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106458 · Cited by 14
Kim, Y., Zhang, F., Su, K. A., Larochelle, M. R., Callahan, M., Fisher, D. E., Wharam, J. F., & Asgari, M. M. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06001-y · Cited by 14
Five-year Trends in Opioid Prescribing Following Orthopaedic Trauma
Flanagan, C. D., Joseph, N. M., Benedick, A., & Vallier, H. A. (2020) · JAAOS Global Research and Reviews · doi:10.5435/jaaosglobal-d-20-00134 · Cited by 14
Nonmedical use of prescription opioids, psychological distress, and suicidality among adolescents
Sampasa‐Kanyinga, H., Kanyinga, F. B., Chaput, J., Hamilton, H. A., Elton‐Marshall, T., & Colman, I. (2020) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-020-01958-x · Cited by 14
The Indianapolis harmspot policing experiment
Carter, J. G., Mohler, G., Raje, R., Chowdhury, N., & Pandey, S. (2021) · Journal of Criminal Justice · doi:10.1016/j.jcrimjus.2021.101814 · Cited by 14
The role of preoperative opioid use in shoulder surgery—A systematic review
Al-Mohrej, O. A., Prada, C., Madden, K., Shanthanna, H., Leroux, T. S., & Khan, M. (2022) · Shoulder & Elbow · doi:10.1177/17585732211070193 · Cited by 14
Designer drugs: a medicinal chemistry perspective (II)
Carroll, F. I., Lewin, A. H., Mascarella, S. W., Seltzman, H. H., & Reddy, P. A. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14349 · Cited by 14
Hasan, M. M., Noor‐E‐Alam, M., Shi, J., Young, L. D., & Young, G. J. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2065638 · Cited by 14
Oser, C. B., Batty, E. J., Booty, M. D., Eddens, K. S., Knudsen, H. K., Perry, B. L., Rockett, M., & Staton, M. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066068 · Cited by 14
Office-Based Buprenorphine Treatment
Noe, S. R., & Keller, T. (2020) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000320 · Cited by 14
Abraham, A. J., Andrews, C. M., Grogan, C. M., Pollack, H. A., D’Aunno, T. A., Humphreys, K. N., & Friedmann, P. D. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201700196 · Cited by 14
Postoperative Opioid Prescription Reduction Strategy in a Regional Healthcare System
Frazee, R. C., Garmon, E. H., Isbell, C. L., Bird, E. T., & Papaconstantinou, H. T. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.12.023 · Cited by 14
Salazar, A., Moreno-Pulido, S., Sola, H. D., Moral-Muñoz, J. A., Dueñas, M., & Failde, I. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1684251 · Cited by 14
Brown, R., Deyo, B. M. F., Nicholas, C. R. N., Baltes, A., Hetzel, S., Tilhou, A. S., Quanbeck, A., Glass, J. E., O’Rourke, A. P., & Agarwal, S. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109286 · Cited by 13
Causa, L., Tapia, J. E., Valenzuela, A., Benalcazar, D., Droguett, E. L., & Busch, C. (2023) · Expert Systems with Applications · doi:10.1016/j.eswa.2023.122808 · Cited by 15
Pain management and prescribing practices in otolaryngology residency programs
Klimczak, J., Badhey, A. K., Wong, A., Colley, P. M., & Teng, M. S. (2019) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2019.07.009 · Cited by 13
Interdisciplinary Pain Management Programs in the Treatment of Pain Conditions
Brecht, D. M., Stephens, J., & Gatchel, R. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-39982-5_18 · Cited by 13
A Data-Driven Mathematical Model of the Heroin and Fentanyl Epidemic in Tennessee
Phillips, T., Lenhart, S., & Strickland, C. (2021) · Bulletin of Mathematical Biology · doi:10.1007/s11538-021-00925-0 · Cited by 13
Lombana, N. F., Falola, R. A., Zolfaghari, K., Roth, C., Abraham, J. T., & Saint‐Cyr, M. (2022) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009398 · Cited by 13
Cui, Z., Hayashi, K., Bach, P., Dong, H., Milloy, M., & Kerr, T. H. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109624 · Cited by 13
Peck, K. R., Badger, G. J., Cole, R., Higgins, S. T., Moxley‐Kelly, N., & Sigmon, S. C. (2023) · Addictive Behaviors · doi:10.1016/j.addbeh.2023.107688 · Cited by 13
Shtrichman, R., Conrad, S., Schimo, K., Shachar, R., Machluf, E., Mindal, E., Epstein, H., Epstein, S., & Paz, A. (2018) · JMIR Human Factors · doi:10.2196/10128 · Cited by 13
A scoping review exploring the opioid prescribing practices of US dental professionals
Lutfiyya, M. N., Gross, A. J., Schvaneveldt, N., Woo, A., & Lipsky, M. S. (2018) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2018.07.017 · Cited by 13
Postoperative Opioid Prescribing Following Gynecologic Surgery for Pelvic Organ Prolapse
Leach, D. A., Habermann, E. B., Glasgow, A. E., & Occhino, J. A. (2018) · Urogynecology · doi:10.1097/spv.0000000000000628 · Cited by 13
Phillips, A. L., Thiese, M. S., Freeman, M., Kartchner, R., & Hegmann, K. T. (2019) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001640 · Cited by 13
High Parental Anxiety Increases Narcotic Use in Adolescent Patients Following Spinal Fusion
Sarkisova, N., Andras, L. M., Yang, J., Tolo, V. T., & Skaggs, D. L. (2020) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0000000000001549 · Cited by 13
Huang, Y., Jacobson, J. S., Tergas, A. I., Ananth, C. V., Neugut, A. I., Hershman, D. L., & Wright, J. D. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003948 · Cited by 13
A national evaluation of opioid prescribing and persistent use after ambulatory anorectal surgery
Keller, D. S., Kenney, B. C., Harbaugh, C. M., Waljee, J. F., & Brummett, C. M. (2020) · Surgery · doi:10.1016/j.surg.2020.11.006 · Cited by 13
An Ethicolegal Analysis of Involuntary Treatment for Opioid Use Disorders
Udwadia, F. R., & Illes, J. (2020) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110520979383 · Cited by 13
Franz, B. A., Dhanani, L. Y., & Brook, D. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00242-w · Cited by 13
Patel, M. S., Cicali, E. J., & Orlando, F. A. (2025) · The Pharmacogenomics Journal · doi:10.1038/s41397-025-00376-z · Cited by 12
Appetitive Needs and Addiction
Sussman, S. Y., & Pakdaman, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.004 · Cited by 12
Zhang, Y., Nathan, J. B., Moreno, A., Merkel, R., Kahng, M. W., Hayes, M. R., Reiner, B. C., Crist, R. C., & Schmidt, H. D. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01634-z · Cited by 12
Opioids and Cancer: Current Understanding and Clinical Considerations
Sah, D. K., Shoffel‐Havakuk, H., Tsur, N., Uhelski, M. L., Gottumukkala, V. N. R., & Cata, J. P. (2024) · Current Oncology · doi:10.3390/curroncol31060235 · Cited by 12
Perioperative Pain Management in Hand and Upper Extremity Surgery
Neumeister, E. L., Beason, A. M., Thayer, J. A., & Bitar, Y. E. (2020) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2019.12.004 · Cited by 12
Wei, H., Zhang, T., Zhan, C., & Zheng, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108128 · Cited by 12
Economic burden of opioid crisis and the role of pharmacist-led interventions
Sanyal, C. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2020.11.006 · Cited by 12
Velez, F. F., Colman, S., Kauffman, L., Ruetsch, C. R., Anastassopoulos, K. P., & Maricich, Y. A. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s334274 · Cited by 12
Investigating individual differences in opioid-taking and opioid-seeking behavior in male rats
Chang, S. E., Krueger, L., & Flagel, S. B. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06023-2 · Cited by 12
Jeffrey, K. N., Thelen, A. E., Dreimiller, A., Tollinche, L. E., Alkhatib, H., Dorsey, A., & El-Hayek, K. M. (2022) · Surgery · doi:10.1016/j.surg.2022.07.053 · Cited by 12
Kim, S., & Suh, H. S. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.103953 · Cited by 12
Gabriel, R. A., Simpson, S., Zhong, W., Burton, B. N., Mehdipour, S., & Said, E. T. (2023) · JMIR Perioperative Medicine · doi:10.2196/40455 · Cited by 12
Witkiewitz, K. A., & Vowles, K. E. (2023) · Current Directions in Psychological Science · doi:10.1177/09637214231162366 · Cited by 13
Trends and characteristics of naloxone therapy reported to US poison centers
Rege, S. V., Ngo, A. D., Ait‐Daoud, N., Sharma, S., Verplancken, E., & Holstege, C. P. (2018) · Addiction · doi:10.1111/add.14378 · Cited by 12
Association Between State Medicaid Eligibility Thresholds and Deaths Due to Substance Use Disorders
Snider, J. T., Duncan, M. E., Gore, M. R., Seabury, S. A., Silverstein, A. R., Tebeka, M. G., & Goldman, D. P. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3056 · Cited by 12
We Need a Taxonomy of State-Level Opioid Policies
Grant, S., Smart, R., & Stein, B. D. (2020) · JAMA Health Forum · doi:10.1001/jamahealthforum.2020.0050 · Cited by 12
Jenkins, G. J., Cleveland, M. J., Knapp, K. S., Bunce, S. C., & Cleveland, H. H. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106674 · Cited by 12
Metadata
- Authors
- Florence, C. S., Zhou, C., Luo, F., & Xu, L.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Medical Care
- Published
- 2016-10
- Volume
- 54
- Issue
- 10
- Pages
- 901-906
- ISSN
- 0025-7079 (ISSN-L)
- PMC
- PMC5975355
- OpenAlex
- W2519105412
- Cited by
- 1,152
- References
- 15
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 51 · 2023: 79 · 2022: 125 · 2021: 195 · 2020: 265 · 2019: 185 · 2018: 128 · 2017: 45 · 2016: 5
- FWCI
- 119.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Medical Care (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- prescription opioid overdose, opioid abuse, opioid use disorder, economic burden, social costs, health care costs, criminal justice costs, productivity loss, fatal overdose, opioid epidemic
- MeSH terms
- Absenteeism, Prescription Drug Overuse, Criminal Law, Female, Humans, Male, Opioid-Related Disorders, United States, Health Care Costs, Cost of Illness, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review